Buy & Sell Bank of New York Mellon Corp (BNY) – Bank of New York Mellon Corp Price Today
Aura AI Summary
Key Stats
- $97.81BMarket Cap
- FinancialsSector
- -5.38%3M Drawdown
- -Enterprise Value
- 1.49%Dividend Yield
- 57 daysTypical Hold Time
Bank of New York Mellon Corp (BNY) is currently valued at a market capitalization of $97.81B. Over the past 52 weeks, Bank of New York Mellon Corp has traded between a low of $89.63 and a high of $144.29, highlighting its annual price range. Over the past three months, Bank of New York Mellon Corp has recorded a drawdown of -5.38%, reflecting recent price volatility. Bank of New York Mellon Corp offers a dividend yield of 1.49%, with the most recent dividend of $0.53 paid on 27 Apr 26. On average, investors hold Bank of New York Mellon Corp for approximately 57 days, indicating typical investor behavior on the platform.
About Bank of New York Mellon Corp
BNY Mellon is a global investment company involved in managing and servicing financial assets throughout the investment lifecycle. The bank provides financial services for institutions, corporations, and individual investors and delivers investment management and investment services in 35 countries and more than 100 markets. BNY Mellon is the largest global custody bank in the world, with about $41.1 trillion in under custody and administration (as of Dec. 31, 2020), and can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute, or restructure investments. BNY Mellon's asset-management division manages about $2.2 trillion in assets.
Most Recent News
Capital Link Shipping launches new CEO insights on tanker markets, maritime resilience, and capital markets.
Capital Link Shipping has expanded its Maritime Intelligence Hub with new executive insights from leaders at Scorpio Tankers, DHT Holdings, d’Amico International Shipping, and others. These discussions cover market trends in crude oil and product tan...
Centene offers voluntary staff buyouts amid major ACA membership drop
Centene, a major U.S. health insurer, has launched a voluntary separation program allowing eligible employees to apply for buyouts as it faces a significant decline in membership, especially in its Affordable Care Act (ACA) marketplace plans. Members...
US agency proposes broader Medicare coverage for heart valve device, boosting Edwards Lifesciences.
The US Centers for Medicare & Medicaid Services (CMS) proposed removing the coverage with evidence development (CED) requirement for Transcatheter Aortic Valve Replacement (TAVR) in patients with symptomatic severe aortic stenosis. CMS also suggested...